
CP-SCD
News & Events
-
April 8, 2021
CP-SCD Announces Pfizer Executive as its First Industry Co-Director
C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its first Industry Co-Director. David is a pediatrician/pediatric hematologist/oncologist who, prior to transitioning to clinical research in the pharmaceutical industry, spent 18 years in clinical practice, with a focus on clinical care and research for pediatric......